VIRACEPT What is VIRACEPT?

(nelfinavir mesylate)

What is VIRACEPT?

VIRACEPT is a prescription HIV-1 medicine used with other HIV-1 medicines to treat human immunodeficiency virus (HIV-1) infection. HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS).

It is not known if VIRACEPT is safe and effective in children less than 2 years of age.

Do not take VIRACEPT if you:

•
are taking any of the following medicines. VIRACEPT may cause serious life-threatening side effects or death when used with these medicines:
o
alfuzosin
o
amiodarone
o
cisapride
o
ergot-containing medicines:
▪
dihydroergotamine
▪
ergotamine
▪
methylergonovine
o
lovastatin
o
lurasidone
o
midazolam, when taken by mouth for sedation
o
pimozide
o
quinidine
o
rifampin
o
sildenafil (Revatio), when used for the treatment of pulmonary arterial hypertension (PAH)
o
simvastatin
o
St. John's wort (Hypericum perforatum)
o
triazolam

Before taking VIRACEPT, tell your healthcare provider about all of your medical conditions, including if you:

•
have liver problems
•
have kidney problems
•
have phenylketonuria. VIRACEPT Oral Powder contains aspartame.
•
have high blood sugar (diabetes)
•
have hemophilia
•
are pregnant or plan to become pregnant. VIRACEPT may harm your unborn baby.
o
Tell your healthcare provider right away if you become pregnant during treatment with VIRACEPT.
o
Hormonal forms of birth control, such as injections, vaginal rings or implants, contraceptive patches, and some birth control pills may not work during treatment with VIRACEPT. Talk to your healthcare provider about forms of birth control that may be used during treatment with VIRACEPT.
o
Pregnancy Registry. There is a pregnancy registry for women who take VIRACEPT during pregnancy. The purpose of the registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry.
•
are breastfeeding or plan to breastfeed. Do not breastfeed if you take VIRACEPT.
o
You should not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby.
o
VIRACEPT can pass into your breast milk.
o
Talk to your healthcare provider about the best way to feed your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Some medicines interact with VIRACEPT. Keep a list of your medicines to show your healthcare provider and pharmacist.

•
You can ask your healthcare provider or pharmacist for a list of medicines that interact with VIRACEPT.
•
Do not start taking a new medicine without telling your healthcare provider. Your healthcare provider can tell you if it is safe to take VIRACEPT with other medicines.
o
Especially tell your healthcare provider if you take medicines that contain didanosine. Take VIRACEPT with food one hour after or more than two hours before you take didanosine.

Find VIRACEPT medical information:

Find VIRACEPT medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

VIRACEPT Quick Finder

Medication Guide
Download Consumer Medicine Information

Health Professional Information

What is VIRACEPT?

What is VIRACEPT?

VIRACEPT is a prescription HIV-1 medicine used with other HIV-1 medicines to treat human immunodeficiency virus (HIV-1) infection. HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS).

It is not known if VIRACEPT is safe and effective in children less than 2 years of age.

Do not take VIRACEPT if you:

•
are taking any of the following medicines. VIRACEPT may cause serious life-threatening side effects or death when used with these medicines:
o
alfuzosin
o
amiodarone
o
cisapride
o
ergot-containing medicines:
▪
dihydroergotamine
▪
ergotamine
▪
methylergonovine
o
lovastatin
o
lurasidone
o
midazolam, when taken by mouth for sedation
o
pimozide
o
quinidine
o
rifampin
o
sildenafil (Revatio), when used for the treatment of pulmonary arterial hypertension (PAH)
o
simvastatin
o
St. John's wort (Hypericum perforatum)
o
triazolam

Before taking VIRACEPT, tell your healthcare provider about all of your medical conditions, including if you:

•
have liver problems
•
have kidney problems
•
have phenylketonuria. VIRACEPT Oral Powder contains aspartame.
•
have high blood sugar (diabetes)
•
have hemophilia
•
are pregnant or plan to become pregnant. VIRACEPT may harm your unborn baby.
o
Tell your healthcare provider right away if you become pregnant during treatment with VIRACEPT.
o
Hormonal forms of birth control, such as injections, vaginal rings or implants, contraceptive patches, and some birth control pills may not work during treatment with VIRACEPT. Talk to your healthcare provider about forms of birth control that may be used during treatment with VIRACEPT.
o
Pregnancy Registry. There is a pregnancy registry for women who take VIRACEPT during pregnancy. The purpose of the registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry.
•
are breastfeeding or plan to breastfeed. Do not breastfeed if you take VIRACEPT.
o
You should not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby.
o
VIRACEPT can pass into your breast milk.
o
Talk to your healthcare provider about the best way to feed your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Some medicines interact with VIRACEPT. Keep a list of your medicines to show your healthcare provider and pharmacist.

•
You can ask your healthcare provider or pharmacist for a list of medicines that interact with VIRACEPT.
•
Do not start taking a new medicine without telling your healthcare provider. Your healthcare provider can tell you if it is safe to take VIRACEPT with other medicines.
o
Especially tell your healthcare provider if you take medicines that contain didanosine. Take VIRACEPT with food one hour after or more than two hours before you take didanosine.
Prescribing Information
Download Prescribing Information

Health Professional Information

What is VIRACEPT?

What is VIRACEPT?

VIRACEPT is a prescription HIV-1 medicine used with other HIV-1 medicines to treat human immunodeficiency virus (HIV-1) infection. HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS).

It is not known if VIRACEPT is safe and effective in children less than 2 years of age.

Do not take VIRACEPT if you:

•
are taking any of the following medicines. VIRACEPT may cause serious life-threatening side effects or death when used with these medicines:
o
alfuzosin
o
amiodarone
o
cisapride
o
ergot-containing medicines:
▪
dihydroergotamine
▪
ergotamine
▪
methylergonovine
o
lovastatin
o
lurasidone
o
midazolam, when taken by mouth for sedation
o
pimozide
o
quinidine
o
rifampin
o
sildenafil (Revatio), when used for the treatment of pulmonary arterial hypertension (PAH)
o
simvastatin
o
St. John's wort (Hypericum perforatum)
o
triazolam

Before taking VIRACEPT, tell your healthcare provider about all of your medical conditions, including if you:

•
have liver problems
•
have kidney problems
•
have phenylketonuria. VIRACEPT Oral Powder contains aspartame.
•
have high blood sugar (diabetes)
•
have hemophilia
•
are pregnant or plan to become pregnant. VIRACEPT may harm your unborn baby.
o
Tell your healthcare provider right away if you become pregnant during treatment with VIRACEPT.
o
Hormonal forms of birth control, such as injections, vaginal rings or implants, contraceptive patches, and some birth control pills may not work during treatment with VIRACEPT. Talk to your healthcare provider about forms of birth control that may be used during treatment with VIRACEPT.
o
Pregnancy Registry. There is a pregnancy registry for women who take VIRACEPT during pregnancy. The purpose of the registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry.
•
are breastfeeding or plan to breastfeed. Do not breastfeed if you take VIRACEPT.
o
You should not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby.
o
VIRACEPT can pass into your breast milk.
o
Talk to your healthcare provider about the best way to feed your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Some medicines interact with VIRACEPT. Keep a list of your medicines to show your healthcare provider and pharmacist.

•
You can ask your healthcare provider or pharmacist for a list of medicines that interact with VIRACEPT.
•
Do not start taking a new medicine without telling your healthcare provider. Your healthcare provider can tell you if it is safe to take VIRACEPT with other medicines.
o
Especially tell your healthcare provider if you take medicines that contain didanosine. Take VIRACEPT with food one hour after or more than two hours before you take didanosine.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.